STOCK TITAN

Telkom Indonesia (TLK) sells full AdMedika stake in portfolio shake-up

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

PT Telkom Indonesia (Persero) Tbk reports that its subsidiaries PT Multimedia Nusantara (TelkomMetra) and PT Metra Digital Investama Ventura (MDI) have divested their entire equity stake in AdMedika Group. The transaction covers 452,330 shares, representing 100% of AdMedika’s capital, sold to Global Assistance & Healthcare Singapore Pte, Ltd. (Fullerton) via a Share Purchase Arrangement.

Telkom explains that this move is part of a broader transformation to become a Strategic Holding focused on digital infrastructure, integrated B2C services, B2B ICT services, and international business. The divestment is described as streamlining a non-core portfolio, expected to support value creation and generate returns on a consolidated basis, while not having a material impact on Telkom’s operations, legal standing, financial condition, or business continuity.

Positive

  • None.

Negative

  • None.

Insights

Telkom streamlines non-core health-admin unit with full AdMedika sale.

PT Telkom Indonesia is divesting 452,330 AdMedika Group shares, equal to 100% ownership, to Fullerton. This aligns with management’s shift toward four strategic pillars centred on digital infrastructure and ICT services.

The company characterizes AdMedika as part of a non-core portfolio and states the sale is intended to unlock value and support its role as a Strategic Holding. Telkom also notes the divestment has no material impact on operations, legal standing, financial condition, or business continuity, suggesting the asset is relatively small within the group.

Investors can read this as a portfolio-tidying move rather than a transformational step. Future disclosures in regular reports may show how proceeds and any returns from this inorganic initiative contribute to consolidated results and whether further non-core divestments follow the same pattern.

AdMedika shares sold 452,330 shares 100% of AdMedika Group capital divested
TelkomMetra pre-sale ownership 452,329 shares (99.99%) Direct shareholding in AdMedika Group
MDI pre-sale ownership 1 share (0.01%) Minority shareholding in AdMedika Group
Event date June 2, 2026 Date of AdMedika divestment
Strategic pillars 4 pillars Digital infrastructure, B2C, B2B ICT, International
divestiture financial
"Divestiture of TelkomMetra’s entire equity stake in AdMedika Group"
Divestiture is the process of selling or getting rid of a part of a company, such as a division or asset. It often happens when a business wants to focus on its core activities or improve its finances. For investors, divestitures can signal strategic shifts or influence the company's value, affecting investment decisions.
Share Purchase Arrangement financial
"through a divestment scheme (100%) ... through a Share Purchase Arrangement (SPA)"
Strategic Holding financial
"Telkom Group’s ongoing transformation to be a Strategic Holding"
non-core portfolio financial
"streamlining its current non-core portfolio, so that in the future TELKOM will be more focused"
inorganic business initiative financial
"This inorganic business initiative is expected to generate returns for Telkom Group"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction did PT Telkom Indonesia (TLK) report regarding AdMedika Group?

PT Telkom Indonesia reported that subsidiaries TelkomMetra and MDI divested their entire equity stake in AdMedika Group, selling 452,330 shares representing 100% of its capital to Global Assistance & Healthcare Singapore Pte, Ltd. (Fullerton) under a Share Purchase Arrangement.

When did Telkom (TLK) complete the divestiture of AdMedika Group?

Telkom completed the divestiture of AdMedika Group on June 2, 2026. On that date, TelkomMetra and MDI transferred all 452,330 AdMedika shares, corresponding to 100% ownership, to Global Assistance & Healthcare Singapore Pte, Ltd. as the selected purchaser.

How much of AdMedika Group did TelkomMetra and MDI own before the sale?

Before the sale, TelkomMetra owned 452,329 AdMedika shares, equal to 99.99% of AdMedika Group, while MDI held 1 share, equal to 0.01%. Together, they controlled 452,330 shares, representing 100% of the company’s capital.

Who bought Telkom’s stake in AdMedika Group from TelkomMetra and MDI?

The buyer of TelkomMetra and MDI’s entire stake in AdMedika Group is Global Assistance & Healthcare Singapore Pte, Ltd., referred to as Fullerton. The transaction was executed through a Share Purchase Arrangement as part of Telkom Group’s portfolio restructuring efforts.

How does the AdMedika divestment affect Telkom’s financial condition and operations?

Telkom states that divesting TelkomMetra’s entire equity stake in AdMedika Group does not have any material impact on its operational activities, legal standing, financial condition, or business continuity, while it is expected to generate returns on a consolidated basis for Telkom Group.

Why is Telkom (TLK) divesting its stake in AdMedika Group?

Telkom explains the divestment supports its transformation into a Strategic Holding focused on four pillars and the streamlining of non-core portfolio assets. The company aims to be more focused, agile, and competitive globally while unlocking value from the AdMedika Group divestment.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13 a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Perusahaan Perseroan (Persero)

PT Telekomunikasi Indonesia Tbk

(Exact name of Registrant as specified in its charter)

Telecommunications Indonesia

(A state-owned public limited liability Company)

(Translation of registrant’s name into English)

Jl. Japati No. 1 Bandung 40133, Indonesia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F þ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No þ

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No þ


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: June 3, 2026

Perusahaan Perseroan (Persero)

PT Telekomunikasi Indonesia Tbk

By: /s/ Jati Widagdo

----------------------------------------------------

(Signature)

Jati Widagdo

SVP Corporate Secretary


Graphic

Number

:

Tel.42/LP 000/COP-M0000000/2026

Jakarta,

June 3, 2026

To

Board of Commissioners of the Indonesian Financial Services Authority

Attn. Chief Executive of Capital Market Supervision, Derivative Finance and Carbon Exchanges

Sumitro Djojohadikusumo Building

Jl. Lapangan Banteng Timur No.2-4

Jakarta 10710

Re

:

Divestiture of TelkomMetra’s entire equity stake in AdMedika Group

Dear Sir/Madam,

In compliance with the Indonesian Financial Service Authority’s (Otoritas Jasa Keuangan/”OJK”) Regulation No. 31/POJK.04/2015 on Disclosure of Material Information or Facts by Issuers or Public Companies, as lastly amended by OJK Regulation No. 45 of 2024 on Development and Reinforcement of Issuers and Public Companies, we hereby inform you that:

Issuer Name

:

PT Telkom Indonesia (Persero) Tbk

Business Sector

:

Telecommunication

Phone

:

(021) 5215109

E-mail Address

:

investor@telkom.co.id

1.

Information or Material Facts

Divestiture of TelkomMetra’s entire equity stake in AdMedika Group

2.

Date

June 2, 2026

3.

Description

PT Telkom Indonesia (Persero) Tbk (“TELKOM”) enhances its business fundamentals by restructuring its portfolio and transitioning into four Strategic Holding pillars: Digital infrastructure, integrated B2C service, B2B ICT service, and International.

To strengthen its business fundamentals and portfolio restructuring, TELKOM is also streamlining its current non-core portfolio, so that in the future TELKOM will be more focused, agile, and competitive on the global stage.

As part of the implementation of this transformation, on June 2, 2026, PT Multimedia Nusantara (“TELKOMMETRA”), as a direct subsidiary of Telkom, alongside PT Metra Digital Investama Ventura (“MDI”), divested their entire shareholdings in PT Administrasi Medika (“AdMedika”).

This corporate action was executed not only simplifying portfolio, but also to unlock value, and align with PT Danantara Asset Management Persero (“DAM”)’s strategic aspirations regarding subsidiary streamlining in State-Owned Enterprises.

Subsequently, this transaction proceeded through a divestment scheme (100%) of TelkomMetra and MDI’s entire ownership in AdMedika Group through a Share Purchase Arrangement (SPA) with Global Assistance & Healthcare Singapore Pte, Ltd. (“FULLERTON”) as the Selected Purchaser. The series of transactions detailed as follows:


Graphic

1.
Subject Shares

452.330 (Four hundred fifty two thousand three hundred thirty) shares, or 100% of the entire capital injected in AdMedika Group.

2.
Seller
i.
TelkomMetra: 99.99% Shareholder of AdMedika Group  (452.329 shares)
ii.
MDI: 0.01% Shareholder of AdMedika Group (1 share)

3.
Purchaser

Global Assistance & Healthcare Singapore Pte, Ltd. (Fullerton)

This corporate action is expected to support Telkom Group’s ongoing transformation to be a Strategic Holding and to maximize value creation from the divestment of AdMedika Group.

4.

The Impact of the Events

This inorganic business initiative is expected to generate returns for Telkom Group on a consolidated basis.

5.

Others

The divestment of TelkomMetra’s entire equity stake in AdMedika Group does not have any material impact on the operational activities, legal standing, financial condition, or business continuity of Telkom.

Thus, we submit this report. Thank you for your attention.

Best regards,

/s/ Jati Widagdo

Jati Widagdo

SVP Corporate Secretary